---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-043419"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2026-06-16T12:07:31+00:00"
generated_at: "2026-06-16T12:10:12.687398+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Sanuwave cuts Q2 2026 revenue guidance to $8.5-9.5M on Ultramist market disruption

## Summary
- Revenue guidance for Q2 2026 reduced to $8.5-$9.5M from prior guidance provided on May 13.
- Downgrade driven by CMS reimbursement clawbacks causing wound care practice closures and cannibalization from used Ultramist systems.
- Applicator consumables on pace for record quarterly unit volume in Q2.
- CEO Morgan Frank sees positive applicator outlook but near-term headwinds from capital sales.

## SEC filing metadata
- accession: 0001628280-26-043419
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2026-06-16T12:07:31+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000162828026043419/0001628280-26-043419-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000162828026043419/snwv-20260616.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-043419
- JSON: https://secwatch.observer/filing/0001628280-26-043419.json
- Plain text: https://secwatch.observer/filing/0001628280-26-043419.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.